$0.2501
0.002601.05%
At close: -
$0.2452
-0.00490-1.96%
After Hours: Dec 20, 7:50 PM EDT
Comments
Loading...
Eterna Therapeutics (NASDAQ:ERNA) Stock, Earnings Estimates, EPS, And Revenue
Eterna Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Nov 12
EPS
$-4.920
Quarterly Revenue
$487K
Annual Revenue
(as of Sep 30)
(as of Sep 30)
$598K
Analyze the earnings history of Eterna Therapeutics using advanced sorting and filters.
Data brought to you by Benzinga APIs
Eterna Therapeutics (ERNA) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
Eterna Therapeutics (ERNA) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
FAQ
When is Eterna Therapeutics (NASDAQ:ERNA) reporting earnings?
Eterna Therapeutics (ERNA) is scheduled to report earnings on March 13, 2025. The last reported earnings were for reported on November 12, 2024 for Q3.
What were the latest earnings per share (EPS) for Eterna Therapeutics (NASDAQ:ERNA)?
The Actual EPS was $-4.92, which missed the estimate of $0.00.
What were Eterna Therapeutics’s (NASDAQ:ERNA) revenues?
The Actual Revenue was $487K, which beat the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.